Alan M Fogelman

Title(s)Professor, Medicine
SchoolMedicine
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Alan M. Fogelman holds the Castera Chair in Cardiology.

    Collapse Research 
    Collapse Research Activities and Funding
    Targeting the Enterocyte to Prevent Vascular Inflammation
    NIH R01HL148286Jun 1, 2019 - May 31, 2023
    Role: Principal Investigator
    GORDON RESEARCH CONFERENCE ON ATHEROSCLEROSIS 1989
    NIH R13HL042904Jun 18, 1989 - Jun 17, 1990
    Role: Principal Investigator
    Lipid and Lipoprotein Metabolism in Atherosclerosis
    NIH P01HL030568Jul 1, 1983 - Apr 30, 2020
    Role: Principal Investigator
    PATHOPHYSIOLOGY OF MYOCARDIAL DISEASE
    NIH T32HL007412Jul 1, 1978 - Jun 30, 1994
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The multiple roles of lysophosphatidic acid in vascular disease and atherosclerosis. Curr Opin Lipidol. 2023 10 01; 34(5):196-200. Chattopadhyay A, Reddy ST, Fogelman AM. PMID: 37497844.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    2. Role of enterocyte Enpp2 and autotaxin in regulating lipopolysaccharide levels, systemic inflammation, and atherosclerosis. J Lipid Res. 2023 05; 64(5):100370. Chattopadhyay A, Mukherjee P, Sulaiman D, Wang H, Girjalva V, Dorreh N, Jacobs JP, Delk S, Moolenaar WH, Navab M, Reddy ST, Fogelman AM. PMID: 37059333; PMCID: PMC10200992.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    3. The role of gut-derived oxidized lipids and bacterial lipopolysaccharide in systemic inflammation and atherosclerosis. Curr Opin Lipidol. 2022 10 01; 33(5):277-282. Wang H, Reddy ST, Fogelman AM. PMID: 35979993; PMCID: PMC9581106.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    4. Macrophage COX2 Mediates Efferocytosis, Resolution Reprogramming, and Intestinal Epithelial Repair. Cell Mol Gastroenterol Hepatol. 2022; 13(4):1095-1120. Meriwether D, Jones AE, Ashby JW, Solorzano-Vargas RS, Dorreh N, Noori S, Grijalva V, Ball AB, Semis M, Divakaruni AS, Mack JJ, Herschman HR, Martin MG, Fogelman AM, Reddy ST. PMID: 35017061; PMCID: PMC8873959.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    5. ApoA-I mimetics reduce systemic and gut inflammation in chronic treated HIV. PLoS Pathog. 2022 01; 18(1):e1010160. Daskou M, Mu W, Sharma M, Vasilopoulos H, Heymans R, Ritou E, Rezek V, Hamid P, Kossyvakis A, Sen Roy S, Grijalva V, Chattopadhyay A, Kitchen SG, Fogelman AM, Reddy ST, Kelesidis T. PMID: 34995311; PMCID: PMC8740974.
      View in: PubMed   Mentions: 5     Fields:    
    6. Oxidized phospholipids cause changes in jejunum mucus that induce dysbiosis and systemic inflammation. J Lipid Res. 2022 01; 63(1):100153. Mukherjee P, Chattopadhyay A, Grijalva V, Dorreh N, Lagishetty V, Jacobs JP, Clifford BL, Vallim T, Mack JJ, Navab M, Reddy ST, Fogelman AM. PMID: 34808192; PMCID: PMC8953663.
      View in: PubMed   Mentions: 5     Fields:    
    7. Forty-Year Anniversary of Arteriosclerosis, Thrombosis, and Vascular Biology. Arterioscler Thromb Vasc Biol. 2021 09; 41(9):2353-2356. Daugherty A, Fisher EA, Taubman MB, Heistad DD, Fogelman AM. PMID: 34432483; PMCID: PMC8393668.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    8. Apolipoprotein A-I mimetics attenuate macrophage activation in chronic treated HIV. AIDS. 2021 03 15; 35(4):543-553. Mu W, Sharma M, Heymans R, Ritou E, Rezek V, Hamid P, Kossyvakis A, Sen Roy S, Grijalva V, Chattopadhyay A, Papesh J, Meriwether D, Kitchen SG, Fogelman AM, Reddy ST, Kelesidis T. PMID: 33306550; PMCID: PMC8010648.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    9. Apolipoprotein mimetics in cancer. Semin Cancer Biol. 2021 08; 73:158-168. Delk SC, Chattopadhyay A, Escola-Gil JC, Fogelman AM, Reddy ST. PMID: 33188891; PMCID: PMC8110614.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    10. Genetic Regulation of Atherosclerosis-Relevant Phenotypes in Human Vascular Smooth Muscle Cells. Circ Res. 2020 12 04; 127(12):1552-1565. Aherrahrou R, Guo L, Nagraj VP, Aguhob A, Hinkle J, Chen L, Yuhl Soh J, Lue D, Alencar GF, Boltjes A, van der Laan SW, Farber E, Fuller D, Anane-Wae R, Akingbesote N, Manichaikul AW, Ma L, Kaikkonen MU, Björkegren JLM, Önengüt-Gümüscü S, Pasterkamp G, Miller CL, Owens GK, Finn A, Navab M, Fogelman AM, Berliner JA, Civelek M. PMID: 33040646; PMCID: PMC7718324.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    11. Oral 15-Hydroxyeicosatetraenoic Acid Induces Pulmonary Hypertension in Mice by Triggering T Cell-Dependent Endothelial Cell Apoptosis. Hypertension. 2020 09; 76(3):985-996. Ruffenach G, O'Connor E, Vaillancourt M, Hong J, Cao N, Sarji S, Moazeni S, Papesh J, Grijalva V, Cunningham CM, Shu L, Chattopadhyay A, Tiwari S, Mercier O, Perros F, Umar S, Yang X, Gomes AV, Fogelman AM, Reddy ST, Eghbali M. PMID: 32713273; PMCID: PMC8008496.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    12. The role of the small intestine in modulating metabolism and inflammation in atherosclerosis and cancer. Curr Opin Lipidol. 2019 10; 30(5):383-387. Mukherjee P, Chattopadhyay A, Fogelman AM. PMID: 31356236; PMCID: PMC6953609.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    13. Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model. J Clin Invest. 2019 06 11; 129(9):3670-3685. Meriwether D, Sulaiman D, Volpe C, Dorfman A, Grijalva V, Dorreh N, Solorzano-Vargas RS, Wang J, O'Connor E, Papesh J, Larauche M, Trost H, Palgunachari MN, Anantharamaiah GM, Herschman HR, Martin MG, Fogelman AM, Reddy ST. PMID: 31184596; PMCID: PMC6715371.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    14. Noggin depletion in adipocytes promotes obesity in mice. Mol Metab. 2019 07; 25:50-63. Blázquez-Medela AM, Jumabay M, Rajbhandari P, Sallam T, Guo Y, Yao J, Vergnes L, Reue K, Zhang L, Yao Y, Fogelman AM, Tontonoz P, Lusis AJ, Wu X, Boström KI. PMID: 31027994; PMCID: PMC6600080.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    15. Paraoxonase 2 protects against acute myocardial ischemia-reperfusion injury by modulating mitochondrial function and oxidative stress via the PI3K/Akt/GSK-3β RISK pathway. J Mol Cell Cardiol. 2019 04; 129:154-164. Sulaiman D, Li J, Devarajan A, Cunningham CM, Li M, Fishbein GA, Fogelman AM, Eghbali M, Reddy ST. PMID: 30802459.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    16. PON2 Deficiency Leads to Increased Susceptibility to Diet-Induced Obesity. Antioxidants (Basel). 2019 Jan 11; 8(1). Shih DM, Meng Y, Sallam T, Vergnes L, Shu ML, Reue K, Tontonoz P, Fogelman AM, Lusis AJ, Reddy ST. PMID: 30641857; PMCID: PMC6356528.
      View in: PubMed   Mentions: 11  
    17. Role of enterocyte stearoyl-Co-A desaturase-1 in LDLR-null mice. J Lipid Res. 2018 10; 59(10):1818-1840. Mukherjee P, Hough G, Chattopadhyay A, Grijalva V, O'Connor EI, Meriwether D, Wagner A, Ntambi JM, Navab M, Reddy ST, Fogelman AM. PMID: 30139760; PMCID: PMC6168294.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    18. Treating the Intestine with Oral ApoA-I Mimetic Tg6F Reduces Tumor Burden in Mouse Models of Metastatic Lung Cancer. Sci Rep. 2018 06 13; 8(1):9032. Chattopadhyay A, Yang X, Mukherjee P, Sulaiman D, Fogelman HR, Grijalva V, Dubinett S, Wasler TC, Paul MK, Salehi-Rad R, Mack JJ, Iruela-Arispe ML, Navab M, Fogelman AM, Reddy ST. PMID: 29899427; PMCID: PMC5998131.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    19. Paraoxonase 2 overexpression inhibits tumor development in a mouse model of ovarian cancer. Cell Death Dis. 2018 03 12; 9(3):392. Devarajan A, Su F, Grijalva V, Yalamanchi M, Yalamanchi A, Gao F, Trost H, Nwokedi J, Farias-Eisner G, Farias-Eisner R, Fogelman AM, Reddy ST. PMID: 29531225; PMCID: PMC5847560.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    20. Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis. Cell Stem Cell. 2018 02 01; 22(2):206-220.e4. Wang B, Rong X, Palladino END, Wang J, Fogelman AM, Martín MG, Alrefai WA, Ford DA, Tontonoz P. PMID: 29395055; PMCID: PMC5807072.
      View in: PubMed   Mentions: 135     Fields:    Translation:AnimalsCells
    21. Making sense of a seemingly odd connection. Eur Heart J. 2017 12 21; 38(48):3588-3589. Fogelman AM, Reddy ST. PMID: 29020393; PMCID: PMC6251582.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. NOTCH1 is a mechanosensor in adult arteries. Nat Commun. 2017 11 20; 8(1):1620. Mack JJ, Mosqueiro TS, Archer BJ, Jones WM, Sunshine H, Faas GC, Briot A, Aragón RL, Su T, Romay MC, McDonald AI, Kuo CH, Lizama CO, Lane TF, Zovein AC, Fang Y, Tarling EJ, de Aguiar Vallim TQ, Navab M, Fogelman AM, Bouchard LS, Iruela-Arispe ML. PMID: 29158473; PMCID: PMC5696341.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansAnimalsCells
    23. Vascular endothelium plays a key role in directing pulmonary epithelial cell differentiation. J Cell Biol. 2017 10 02; 216(10):3369-3385. Yao J, Guihard PJ, Wu X, Blazquez-Medela AM, Spencer MJ, Jumabay M, Tontonoz P, Fogelman AM, Boström KI, Yao Y. PMID: 28838957; PMCID: PMC5626536.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    24. Oral Apolipoprotein A-I Mimetic D-4F Lowers HDL-Inflammatory Index in High-Risk Patients: A First-in-Human Multiple-Dose, Randomized Controlled Trial. Clin Transl Sci. 2017 Nov; 10(6):455-469. Dunbar RL, Movva R, Bloedon LT, Duffy D, Norris RB, Navab M, Fogelman AM, Rader DJ. PMID: 28795506; PMCID: PMC5673907.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    25. Transgenic tomatoes expressing the 6F peptide and ezetimibe prevent diet-induced increases of IFN-β and cholesterol 25-hydroxylase in jejunum. J Lipid Res. 2017 08; 58(8):1636-1647. Mukherjee P, Hough G, Chattopadhyay A, Navab M, Fogelman HR, Meriwether D, Williams K, Bensinger S, Moller T, Faull KF, Lusis AJ, Iruela-Arispe ML, Bostrom KI, Tontonoz P, Reddy ST, Fogelman AM. PMID: 28592401; PMCID: PMC5538285.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    26. Combined effects of bone morphogenetic protein 10 and crossveinless-2 on cardiomyocyte differentiation in mouse adipocyte-derived stem cells. J Cell Physiol. 2018 Mar; 233(3):1812-1822. Jumabay M, Zhumabai J, Mansurov N, Niklason KC, Guihard PJ, Cubberly MR, Fogelman AM, Iruela-Arispe L, Yao Y, Saparov A, Boström KI. PMID: 28464239; PMCID: PMC5668204.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    27. Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites. Sci Rep. 2017 02 17; 7:42906. Li R, Yang J, Saffari A, Jacobs J, Baek KI, Hough G, Larauche MH, Ma J, Jen N, Moussaoui N, Zhou B, Kang H, Reddy S, Henning SM, Campen MJ, Pisegna J, Li Z, Fogelman AM, Sioutas C, Navab M, Hsiai TK. PMID: 28211537; PMCID: PMC5314329.
      View in: PubMed   Mentions: 38     Fields:    Translation:AnimalsCells
    28. ApoA-I mimetic administration, but not increased apoA-I-containing HDL, inhibits tumour growth in a mouse model of inherited breast cancer. Sci Rep. 2016 11 03; 6:36387. Cedó L, García-León A, Baila-Rueda L, Santos D, Grijalva V, Martínez-Cignoni MR, Carbó JM, Metso J, López-Vilaró L, Zorzano A, Valledor AF, Cenarro A, Jauhiainen M, Lerma E, Fogelman AM, Reddy ST, Escolà-Gil JC, Blanco-Vaca F. PMID: 27808249; PMCID: PMC5093413.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    29. Transintestinal transport of the anti-inflammatory drug 4F and the modulation of transintestinal cholesterol efflux. J Lipid Res. 2016 07; 57(7):1175-93. Meriwether D, Sulaiman D, Wagner A, Grijalva V, Kaji I, Williams KJ, Yu L, Fogelman S, Volpe C, Bensinger SJ, Anantharamaiah GM, Shechter I, Fogelman AM, Reddy ST. PMID: 27199144; PMCID: PMC4918848.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    30. Apolipoprotein E-/- Mice Lacking Hemopexin Develop Increased Atherosclerosis via Mechanisms That Include Oxidative Stress and Altered Macrophage Function. Arterioscler Thromb Vasc Biol. 2016 06; 36(6):1152-63. Mehta NU, Grijalva V, Hama S, Wagner A, Navab M, Fogelman AM, Reddy ST. PMID: 27079878; PMCID: PMC4882257.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    31. Tg6F ameliorates the increase in oxidized phospholipids in the jejunum of mice fed unsaturated LysoPC or WD. J Lipid Res. 2016 05; 57(5):832-47. Chattopadhyay A, Navab M, Hough G, Grijalva V, Mukherjee P, Fogelman HR, Hwang LH, Faull KF, Lusis AJ, Reddy ST, Fogelman AM. PMID: 26965826; PMCID: PMC4847630.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    32. Outcomes of a Novel Training Program for Physician-Scientists: Integrating Graduate Degree Training With Specialty Fellowship. J Grad Med Educ. 2016 Feb; 8(1):85-90. Wong MD, Guerrero L, Sallam T, Frank JS, Fogelman AM, Demer LL. PMID: 26913109; PMCID: PMC4763397.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    33. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties. Arterioscler Thromb Vasc Biol. 2016 Feb; 36(2):274-84. Nguyen SD, Maaninka K, Lappalainen J, Nurmi K, Metso J, Öörni K, Navab M, Fogelman AM, Jauhiainen M, Lee-Rueckert M, Kovanen PT. PMID: 26681753; PMCID: PMC4725095.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    34. Proinflammatory high-density lipoprotein results from oxidized lipid mediators in the pathogenesis of both idiopathic and associated types of pulmonary arterial hypertension. Pulm Circ. 2015 Dec; 5(4):640-8. Ross DJ, Hough G, Hama S, Aboulhosn J, Belperio JA, Saggar R, Van Lenten BJ, Ardehali A, Eghbali M, Reddy S, Fogelman AM, Navab M. PMID: 26697171; PMCID: PMC4671738.
      View in: PubMed   Mentions: 28  
    35. Endothelial NOTCH1 is suppressed by circulating lipids and antagonizes inflammation during atherosclerosis. J Exp Med. 2015 Nov 16; 212(12):2147-63. Briot A, Civelek M, Seki A, Hoi K, Mack JJ, Lee SD, Kim J, Hong C, Yu J, Fishbein GA, Vakili L, Fogelman AM, Fishbein MC, Lusis AJ, Tontonoz P, Navab M, Berliner JA, Iruela-Arispe ML. PMID: 26552708; PMCID: PMC4647265.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCells
    36. Further evidence that high-density lipoprotein is a chameleon-like lipoprotein. Eur Heart J. 2015 Nov 14; 36(43):3017-9. Fogelman AM. PMID: 26377399; PMCID: PMC4644254.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    37. Efficacy of tomato concentrates in mouse models of dyslipidemia and cancer. Pharmacol Res Perspect. 2015 Aug; 3(4):e00154. Chattopadhyay A, Grijalva V, Hough G, Su F, Mukherjee P, Farias-Eisner R, Anantharamaiah GM, Faull KF, Hwang LH, Navab M, Fogelman AM, Reddy ST. PMID: 26171234; PMCID: PMC4492730.
      View in: PubMed   Mentions: 13     Fields:    
    38. Apolipoprotein A-I mimetic peptide 4F blocks sphingomyelinase-induced LDL aggregation. J Lipid Res. 2015 Jun; 56(6):1206-21. Nguyen SD, Javanainen M, Rissanen S, Zhao H, Huusko J, Kivelä AM, Ylä-Herttuala S, Navab M, Fogelman AM, Vattulainen I, Kovanen PT, Öörni K. PMID: 25861792; PMCID: PMC4442877.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    39. Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis. J Lipid Res. 2015 Apr; 56(4):871-87. Navab M, Chattopadhyay A, Hough G, Meriwether D, Fogelman SI, Wagner AC, Grijalva V, Su F, Anantharamaiah GM, Hwang LH, Faull KF, Reddy ST, Fogelman AM. PMID: 25646365; PMCID: PMC4373744.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    40. TMAO is both a biomarker and a renal toxin. Circ Res. 2015 Jan 30; 116(3):396-7. Fogelman AM. PMID: 25634968; PMCID: PMC4366001.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    41. Effect of exposure to atmospheric ultrafine particles on production of free fatty acids and lipid metabolites in the mouse small intestine. Environ Health Perspect. 2015 Jan; 123(1):34-41. Li R, Navab K, Hough G, Daher N, Zhang M, Mittelstein D, Lee K, Pakbin P, Saffari A, Bhetraratana M, Sulaiman D, Beebe T, Wu L, Jen N, Wine E, Tseng CH, Araujo JA, Fogelman A, Sioutas C, Navab M, Hsiai TK. PMID: 25170928; PMCID: PMC4286268.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsPHPublic Health
    42. Apolipoprotein A-I mimetics. Curr Opin Lipidol. 2014 Aug; 25(4):304-8. Reddy ST, Navab M, Anantharamaiah GM, Fogelman AM. PMID: 24977978; PMCID: PMC4213064.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    43. Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3p. Circulation. 2014 Aug 26; 130(9):776-85. Sharma S, Umar S, Potus F, Iorga A, Wong G, Meriwether D, Breuils-Bonnet S, Mai D, Navab K, Ross D, Navab M, Provencher S, Fogelman AM, Bonnet S, Reddy ST, Eghbali M. PMID: 24963038; PMCID: PMC4194270.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansAnimalsCells
    44. Trying to harness the potential of HDL: wishful thinking or sound strategy? Eur Heart J. 2014 Dec 07; 35(46):3248-9. Fogelman AM. PMID: 24818600.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    45. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circ Res. 2014 Jan 03; 114(1):171-82. Lüscher TF, Landmesser U, von Eckardstein A, Fogelman AM. PMID: 24385510.
      View in: PubMed   Mentions: 103     Fields:    Translation:HumansAnimals
    46. Searching for a successful HDL-based treatment strategy. Biochim Biophys Acta. 2014 Jan; 1841(1):162-7. Reddy ST, Navab M, Anantharamaiah GM, Fogelman AM. PMID: 24466591.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    47. Protection against ischemia/reperfusion injury by high-density lipoprotein and its components. Circ Res. 2013 Dec 06; 113(12):1281-2. Fogelman AM, Reddy ST, Navab M. PMID: 24311615.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    48. Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid. J Lipid Res. 2013 Dec; 54(12):3403-18. Navab M, Hough G, Buga GM, Su F, Wagner AC, Meriwether D, Chattopadhyay A, Gao F, Grijalva V, Danciger JS, Van Lenten BJ, Org E, Lusis AJ, Pan C, Anantharamaiah GM, Farias-Eisner R, Smyth SS, Reddy ST, Fogelman AM. PMID: 24085744; PMCID: PMC3826687.
      View in: PubMed   Mentions: 34     Fields:    Translation:Animals
    49. Heart failure is associated with impaired anti-inflammatory and antioxidant properties of high-density lipoproteins. Am J Cardiol. 2013 Dec 01; 112(11):1770-7. Kim JB, Hama S, Hough G, Navab M, Fogelman AM, Maclellan WR, Horwich TB, Fonarow GC. PMID: 24050409.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    50. Ambient ultrafine particles alter lipid metabolism and HDL anti-oxidant capacity in LDLR-null mice. J Lipid Res. 2013 Jun; 54(6):1608-1615. Li R, Navab M, Pakbin P, Ning Z, Navab K, Hough G, Morgan TE, Finch CE, Araujo JA, Fogelman AM, Sioutas C, Hsiai T. PMID: 23564731; PMCID: PMC3646462.
      View in: PubMed   Mentions: 40     Fields:    Translation:AnimalsCells
    51. Diesel exhaust induces systemic lipid peroxidation and development of dysfunctional pro-oxidant and pro-inflammatory high-density lipoprotein. Arterioscler Thromb Vasc Biol. 2013 Jun; 33(6):1153-61. Yin F, Lawal A, Ricks J, Fox JR, Larson T, Navab M, Fogelman AM, Rosenfeld ME, Araujo JA. PMID: 23559632.
      View in: PubMed   Mentions: 60     Fields:    Translation:AnimalsCellsPHPublic Health
    52. A novel approach to oral apoA-I mimetic therapy. J Lipid Res. 2013 Apr; 54(4):995-1010. Chattopadhyay A, Navab M, Hough G, Gao F, Meriwether D, Grijalva V, Springstead JR, Palgnachari MN, Namiri-Kalantari R, Su F, Van Lenten BJ, Wagner AC, Anantharamaiah GM, Farias-Eisner R, Farias-Eisener R, Reddy ST, Fogelman AM. PMID: 23378594; PMCID: PMC3606004.
      View in: PubMed   Mentions: 44     Fields:    Translation:Animals
    53. High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature. Arterioscler Thromb Vasc Biol. 2012 Nov; 32(11):2553-60. Navab M, Reddy ST, Van Lenten BJ, Buga GM, Hough G, Wagner AC, Fogelman AM. PMID: 23077141; PMCID: PMC3597084.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    54. Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity. Lipids Health Dis. 2012 Jul 06; 11:87. Kelesidis T, Reddy ST, Huynh D, Meriwether D, Fogelman AM, Navab M, Yang OO. PMID: 22768920; PMCID: PMC3409024.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    55. Apolipoprotein A-I mimetic peptides inhibit expression and activity of hypoxia-inducible factor-1α in human ovarian cancer cell lines and a mouse ovarian cancer model. J Pharmacol Exp Ther. 2012 Aug; 342(2):255-62. Gao F, Chattopadhyay A, Navab M, Grijalva V, Su F, Fogelman AM, Reddy ST, Farias-Eisner R. PMID: 22537771; PMCID: PMC3400800.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    56. LXRα is uniquely required for maximal reverse cholesterol transport and atheroprotection in ApoE-deficient mice. J Lipid Res. 2012 Jun; 53(6):1126-33. Hong C, Bradley MN, Rong X, Wang X, Wagner A, Grijalva V, Castellani LW, Salazar J, Realegeno S, Boyadjian R, Fogelman AM, Van Lenten BJ, Reddy ST, Lusis AJ, Tangirala RK, Tontonoz P. PMID: 22454476; PMCID: PMC3351819.
      View in: PubMed   Mentions: 19     Fields:    Translation:AnimalsCells
    57. HDL mimetics inhibit tumor development in both induced and spontaneous mouse models of colon cancer. Mol Cancer Ther. 2012 Jun; 11(6):1311-9. Su F, Grijalva V, Navab K, Ganapathy E, Meriwether D, Imaizumi S, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R. PMID: 22416044; PMCID: PMC3374063.
      View in: PubMed   Mentions: 43     Fields:    Translation:AnimalsCells
    58. D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice. J Lipid Res. 2012 Mar; 53(3):437-445. Navab M, Reddy ST, Anantharamaiah GM, Hough G, Buga GM, Danciger J, Fogelman AM. PMID: 22167743; PMCID: PMC3276467.
      View in: PubMed   Mentions: 39     Fields:    Translation:Animals
    59. A biochemical fluorometric method for assessing the oxidative properties of HDL. J Lipid Res. 2011 Dec; 52(12):2341-2351. Kelesidis T, Currier JS, Huynh D, Meriwether D, Charles-Schoeman C, Reddy ST, Fogelman AM, Navab M, Yang OO. PMID: 21957198; PMCID: PMC3220300.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    60. Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes. Diabetes. 2011 Oct; 60(10):2617-23. Morgantini C, Natali A, Boldrini B, Imaizumi S, Navab M, Fogelman AM, Ferrannini E, Reddy ST. PMID: 21852676; PMCID: PMC3178289.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    61. Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma. J Lipid Res. 2011 Oct; 52(10):1795-809. Meriwether D, Imaizumi S, Grijalva V, Hough G, Vakili L, Anantharamaiah GM, Farias-Eisner R, Navab M, Fogelman AM, Reddy ST, Shechter I. PMID: 21804067; PMCID: PMC3173006.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    62. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest. 2011 Jul; 121(7):2693-708. Besler C, Heinrich K, Rohrer L, Doerries C, Riwanto M, Shih DM, Chroni A, Yonekawa K, Stein S, Schaefer N, Mueller M, Akhmedov A, Daniil G, Manes C, Templin C, Wyss C, Maier W, Tanner FC, Matter CM, Corti R, Furlong C, Lusis AJ, von Eckardstein A, Fogelman AM, Lüscher TF, Landmesser U. PMID: 21701070; PMCID: PMC3223817.
      View in: PubMed   Mentions: 215     Fields:    Translation:HumansAnimals
    63. Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease. J Natl Med Assoc. 2011 Jun; 103(6):524-33. Vaziri ND, Navab K, Gollapudi P, Moradi H, Pahl MV, Barton CH, Fogelman AM, Navab M. PMID: 21830637; PMCID: PMC3276406.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    64. Dysfunctional high-density lipoprotein and the potential of apolipoprotein A-1 mimetic peptides to normalize the composition and function of lipoproteins. Circ J. 2011; 75(7):1533-8. Imaizumi S, Navab M, Morgantini C, Charles-Schoeman C, Su F, Gao F, Kwon M, Ganapathy E, Meriwether D, Farias-Eisner R, Fogelman AM, Reddy ST. PMID: 21628835; PMCID: PMC3625624.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimals
    65. D-4F, an apoA-I mimetic peptide, inhibits proliferation and tumorigenicity of epithelial ovarian cancer cells by upregulating the antioxidant enzyme MnSOD. Int J Cancer. 2012 Mar 01; 130(5):1071-81. Ganapathy E, Su F, Meriwether D, Devarajan A, Grijalva V, Gao F, Chattopadhyay A, Anantharamaiah GM, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R. PMID: 21425255; PMCID: PMC3248802.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansAnimalsCells
    66. Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally. J Lipid Res. 2011 Jun; 52(6):1200-1210. Navab M, Reddy ST, Anantharamaiah GM, Imaizumi S, Hough G, Hama S, Fogelman AM. PMID: 21444758; PMCID: PMC3090241.
      View in: PubMed   Mentions: 46     Fields:    Translation:AnimalsCells
    67. HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL. Lipids Health Dis. 2011 Feb 23; 10:35. Kelesidis T, Yang OO, Currier JS, Navab K, Fogelman AM, Navab M. PMID: 21345230; PMCID: PMC3049748.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    68. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011 Apr; 8(4):222-32. Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. PMID: 21304474.
      View in: PubMed   Mentions: 242     Fields:    Translation:Humans
    69. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways. Integr Biol (Camb). 2011 Apr; 3(4):479-89. Gao F, Vasquez SX, Su F, Roberts S, Shah N, Grijalva V, Imaizumi S, Chattopadhyay A, Ganapathy E, Meriwether D, Johnston B, Anantharamaiah GM, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R. PMID: 21283904; PMCID: PMC3248743.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    70. Treatment of patients with cardiovascular disease with L-4F, an apo-A1 mimetic, did not improve select biomarkers of HDL function. J Lipid Res. 2011 Feb; 52(2):361-73. Watson CE, Weissbach N, Kjems L, Ayalasomayajula S, Zhang Y, Chang I, Navab M, Hama S, Hough G, Reddy ST, Soffer D, Rader DJ, Fogelman AM, Schecter A. PMID: 21068008; PMCID: PMC3023557.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCells
    71. Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer. Proc Natl Acad Sci U S A. 2010 Nov 16; 107(46):19997-20002. Su F, Kozak KR, Imaizumi S, Gao F, Amneus MW, Grijalva V, Ng C, Wagner A, Hough G, Farias-Eisner G, Anantharamaiah GM, Van Lenten BJ, Navab M, Fogelman AM, Reddy ST, Farias-Eisner R. PMID: 21041624; PMCID: PMC2993420.
      View in: PubMed   Mentions: 112     Fields:    Translation:HumansAnimalsCells
    72. The complexity of high-density lipoproteins. Circulation. 2010 Nov 09; 122(19):1900-1. Fogelman AM. PMID: 20974995.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    73. Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes. Diabetes. 2010 Dec; 59(12):3223-8. Morgantini C, Imaizumi S, Grijalva V, Navab M, Fogelman AM, Reddy ST. PMID: 20826564; PMCID: PMC2992786.
      View in: PubMed   Mentions: 38     Fields:    Translation:AnimalsCells
    74. L-4F differentially alters plasma levels of oxidized fatty acids resulting in more anti-inflammatory HDL in mice. Drug Metab Lett. 2010 Aug; 4(3):139-48. Imaizumi S, Grijalva V, Navab M, Van Lenten BJ, Wagner AC, Anantharamiah GM, Fogelman AM, Reddy ST. PMID: 20642447; PMCID: PMC3037264.
      View in: PubMed   Mentions: 36     Fields:    Translation:AnimalsCells
    75. Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels. Mol Genet Metab. 2010 Sep; 101(1):66-75. Imaizumi S, Grijalva V, Priceman S, Wu L, Su F, Farias-Eisner R, Hama S, Navab M, Fogelman AM, Reddy ST. PMID: 20619710; PMCID: PMC3037189.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    76. Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. Nephrol Dial Transplant. 2010 Nov; 25(11):3525-34. Vaziri ND, Kim HJ, Moradi H, Farmand F, Navab K, Navab M, Hama S, Fogelman AM, Quiroz Y, Rodriguez-Iturbe B. PMID: 20488818; PMCID: PMC2980997.
      View in: PubMed   Mentions: 10     Fields:    Translation:Animals
    77. Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis. Arthritis Res Ther. 2010; 12(3):R93. Woo JM, Lin Z, Navab M, Van Dyck C, Trejo-Lopez Y, Woo KM, Li H, Castellani LW, Wang X, Iikuni N, Rullo OJ, Wu H, La Cava A, Fogelman AM, Lusis AJ, Tsao BP. PMID: 20482780; PMCID: PMC2911877.
      View in: PubMed   Mentions: 25     Fields:    Translation:Animals
    78. Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids. PLoS One. 2010 Apr 14; 5(4):e10181. Ruchala P, Navab M, Jung CL, Hama-Levy S, Micewicz ED, Luong H, Reyles JE, Sharma S, Waring AJ, Fogelman AM, Lehrer RI. PMID: 20418958; PMCID: PMC2854715.
      View in: PubMed   Mentions: 4     Fields:    Translation:Cells
    79. HDL metabolism and activity in chronic kidney disease. Nat Rev Nephrol. 2010 May; 6(5):287-96. Vaziri ND, Navab M, Fogelman AM. PMID: 20308998.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    80. L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation. Arterioscler Thromb Vasc Biol. 2010 Feb; 30(2):283-9. Buga GM, Navab M, Imaizumi S, Reddy ST, Yekta B, Hough G, Chanslor S, Anantharamaiah GM, Fogelman AM. PMID: 19965777; PMCID: PMC2818809.
      View in: PubMed   Mentions: 18     Fields:    Translation:AnimalsCells
    81. HDL as a biomarker, potential therapeutic target, and therapy. Diabetes. 2009 Dec; 58(12):2711-7. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM. PMID: 19940234; PMCID: PMC2780869.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    82. Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum. 2009 Oct; 60(10):2870-9. Charles-Schoeman C, Watanabe J, Lee YY, Furst DE, Amjadi S, Elashoff D, Park G, McMahon M, Paulus HE, Fogelman AM, Reddy ST. PMID: 19790070; PMCID: PMC2828490.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    83. Structure and function of HDL mimetics. Arterioscler Thromb Vasc Biol. 2010 Feb; 30(2):164-8. Navab M, Shechter I, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM. PMID: 19608977; PMCID: PMC2860541.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    84. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int. 2009 Aug; 76(4):437-44. Vaziri ND, Moradi H, Pahl MV, Fogelman AM, Navab M. PMID: 19471321; PMCID: PMC3280585.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    85. Hemoglobin and its scavenger protein haptoglobin associate with apoA-1-containing particles and influence the inflammatory properties and function of high density lipoprotein. J Biol Chem. 2009 Jul 03; 284(27):18292-301. Watanabe J, Grijalva V, Hama S, Barbour K, Berger FG, Navab M, Fogelman AM, Reddy ST. PMID: 19433579; PMCID: PMC2709397.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimals
    86. A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids. J Lipid Res. 2009 Aug; 50(8):1538-47. Navab M, Ruchala P, Waring AJ, Lehrer RI, Hama S, Hough G, Palgunachari MN, Anantharamaiah GM, Fogelman AM. PMID: 19225094; PMCID: PMC2724044.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    87. Apolipoprotein A-I mimetic peptides. Curr Atheroscler Rep. 2009 Jan; 11(1):52-7. Van Lenten BJ, Wagner AC, Anantharamaiah GM, Navab M, Reddy ST, Buga GM, Fogelman AM. PMID: 19080728; PMCID: PMC2856617.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimals
    88. Multiple indications for anti-inflammatory apolipoprotein mimetic peptides. Curr Opin Investig Drugs. 2008 Nov; 9(11):1157-62. Van Lenten BJ, Navab M, Anantharamaiah GM, Buga GM, Reddy ST, Fogelman AM. PMID: 18951294; PMCID: PMC2856620.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimals
    89. The role of dysfunctional HDL in atherosclerosis. J Lipid Res. 2009 Apr; 50 Suppl:S145-9. Navab M, Reddy ST, Van Lenten BJ, Anantharamaiah GM, Fogelman AM. PMID: 18955731; PMCID: PMC2674720.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansAnimalsCells
    90. Is it just paraoxonase 1 or are other members of the paraoxonase gene family implicated in atherosclerosis? Curr Opin Lipidol. 2008 Aug; 19(4):405-8. Reddy ST, Devarajan A, Bourquard N, Shih D, Fogelman AM. PMID: 18607188.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimals
    91. Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest. 2008 Aug; 118(8):2917-28. Cruz D, Watson AD, Miller CS, Montoya D, Ochoa MT, Sieling PA, Gutierrez MA, Navab M, Reddy ST, Witztum JL, Fogelman AM, Rea TH, Eisenberg D, Berliner J, Modlin RL. PMID: 18636118; PMCID: PMC2467381.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    92. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I. J Lipid Res. 2008 Nov; 49(11):2302-11. Van Lenten BJ, Wagner AC, Jung CL, Ruchala P, Waring AJ, Lehrer RI, Watson AD, Hama S, Navab M, Anantharamaiah GM, Fogelman AM. PMID: 18621920; PMCID: PMC2563211.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCells
    93. Treatment with an apolipoprotein A-1 mimetic peptide in combination with pravastatin inhibits collagen-induced arthritis. Clin Immunol. 2008 May; 127(2):234-44. Charles-Schoeman C, Banquerigo ML, Hama S, Navab M, Park GS, Van Lenten BJ, Wagner AC, Fogelman AM, Brahn E. PMID: 18337176.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    94. Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients. J Lipid Res. 2008 Jun; 49(6):1344-52. Bloedon LT, Dunbar R, Duffy D, Pinell-Salles P, Norris R, DeGroot BJ, Movva R, Navab M, Fogelman AM, Rader DJ. PMID: 18323573; PMCID: PMC2386905.
      View in: PubMed   Mentions: 153     Fields:    Translation:HumansCells
    95. Apo A-1 mimetic peptides as atheroprotective agents in murine models. Curr Drug Targets. 2008 Mar; 9(3):204-9. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM. PMID: 18336238.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    96. The effect of apolipoprotein mimetic peptides in inflammatory disorders other than atherosclerosis. Trends Cardiovasc Med. 2008 Feb; 18(2):61-6. Navab M, Anantharamaiah GM, Fogelman AM. PMID: 18308197; PMCID: PMC4365994.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    97. D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet. J Lipid Res. 2008 Jan; 49(1):192-205. Buga GM, Frank JS, Mottino GA, Hakhamian A, Narasimha A, Watson AD, Yekta B, Navab M, Reddy ST, Anantharamaiah GM, Fogelman AM. PMID: 17925450.
      View in: PubMed   Mentions: 29     Fields:    Translation:AnimalsCells
    98. Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits. J Lipid Res. 2007 Nov; 48(11):2344-53. Van Lenten BJ, Wagner AC, Navab M, Anantharamaiah GM, Hama S, Reddy ST, Fogelman AM. PMID: 17693626.
      View in: PubMed   Mentions: 62     Fields:    Translation:AnimalsCells
    99. The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol. 2007 Aug; 18(4):427-34. Ansell BJ, Fonarow GC, Fogelman AM. PMID: 17620860.
      View in: PubMed   Mentions: 74     Fields:    Translation:Humans
    100. Structural requirements for antioxidative and anti-inflammatory properties of apolipoprotein A-I mimetic peptides. J Lipid Res. 2007 Sep; 48(9):1915-23. Anantharamaiah GM, Mishra VK, Garber DW, Datta G, Handattu SP, Palgunachari MN, Chaddha M, Navab M, Reddy ST, Segrest JP, Fogelman AM. PMID: 17570869.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    101. Differential association of hemoglobin with proinflammatory high density lipoproteins in atherogenic/hyperlipidemic mice. A novel biomarker of atherosclerosis. J Biol Chem. 2007 Aug 10; 282(32):23698-707. Watanabe J, Chou KJ, Liao JC, Miao Y, Meng HH, Ge H, Grijalva V, Hama S, Kozak K, Buga G, Whitelegge JP, Lee TD, Farias-Eisner R, Navab M, Fogelman AM, Reddy ST. PMID: 17556366.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimals
    102. Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study. J Rheumatol. 2007 Jul; 34(7):1459-64. Charles-Schoeman C, Khanna D, Furst DE, McMahon M, Reddy ST, Fogelman AM, Paulus HE, Park GS, Gong T, Ansell BJ. PMID: 17552046.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    103. Peptide Mimetics of Apolipoproteins Improve HDL Function. J Clin Lipidol. 2007 May; 1(2):142-7. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Buga GM, Fogelman AM. PMID: 18449337; PMCID: PMC2130772.
      View in: PubMed   Mentions: 6     Fields:    
    104. Adenovirus-mediated expression of human paraoxonase 3 protects against the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2007 Jun; 27(6):1368-74. Ng CJ, Bourquard N, Hama SY, Shih D, Grijalva VR, Navab M, Fogelman AM, Reddy ST. PMID: 17446441.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    105. Decreased obesity and atherosclerosis in human paraoxonase 3 transgenic mice. Circ Res. 2007 Apr 27; 100(8):1200-7. Shih DM, Xia YR, Wang XP, Wang SS, Bourquard N, Fogelman AM, Lusis AJ, Reddy ST. PMID: 17379834; PMCID: PMC3740095.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansAnimals
    106. A novel anti-atherogenic role for COX-2--potential mechanism for the cardiovascular side effects of COX-2 inhibitors. Prostaglandins Other Lipid Mediat. 2007 Aug; 84(1-2):24-33. Narasimha A, Watanabe J, Lin JA, Hama S, Langenbach R, Navab M, Fogelman AM, Reddy ST. PMID: 17643885; PMCID: PMC2701232.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    107. Modifying the anti-inflammatory effects of high-density lipoprotein. Curr Atheroscler Rep. 2007 Jan; 9(1):57-63. Ansell BJ, Fonarow GC, Navab M, Fogelman AM. PMID: 17169248.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    108. Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention. Nat Clin Pract Cardiovasc Med. 2006 Oct; 3(10):540-7. Navab M, Anantharamaiah GM, Reddy ST, Fogelman AM. PMID: 16990839.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    109. Mechanisms of disease: proatherogenic HDL--an evolving field. Nat Clin Pract Endocrinol Metab. 2006 Sep; 2(9):504-11. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fogelman AM. PMID: 16957764.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansAnimals
    110. High-density lipoprotein: is it always atheroprotective? Curr Atheroscler Rep. 2006 Sep; 8(5):405-11. Ansell BJ, Fonarow GC, Fogelman AM. PMID: 16901411.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    111. Paraoxonase-2 deficiency aggravates atherosclerosis in mice despite lower apolipoprotein-B-containing lipoproteins: anti-atherogenic role for paraoxonase-2. J Biol Chem. 2006 Oct 06; 281(40):29491-500. Ng CJ, Bourquard N, Grijalva V, Hama S, Shih DM, Navab M, Fogelman AM, Lusis AJ, Young S, Reddy ST. PMID: 16891303.
      View in: PubMed   Mentions: 67     Fields:    Translation:AnimalsCells
    112. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006 Aug; 54(8):2541-9. McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, Fogelman AM, Hahn BH. PMID: 16868975.
      View in: PubMed   Mentions: 149     Fields:    Translation:HumansCells
    113. Potential clinical utility of high-density lipoprotein-mimetic peptides. Curr Opin Lipidol. 2006 Aug; 17(4):440-4. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, Fogelman AM. PMID: 16832169.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    114. Understanding changes in high density lipoproteins during the acute phase response. Arterioscler Thromb Vasc Biol. 2006 Aug; 26(8):1687-8. Van Lenten BJ, Reddy ST, Navab M, Fogelman AM. PMID: 16857958.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    115. D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet. J Lipid Res. 2006 Oct; 47(10):2148-60. Buga GM, Frank JS, Mottino GA, Hendizadeh M, Hakhamian A, Tillisch JH, Reddy ST, Navab M, Anantharamaiah GM, Ignarro LJ, Fogelman AM. PMID: 16835442.
      View in: PubMed   Mentions: 39     Fields:    Translation:Animals
    116. Synthetic peptides: managing lipid disorders. Curr Opin Lipidol. 2006 Jun; 17(3):233-7. Anantharamaiah G, Navab M, Reddy ST, Garber DW, Datta G, Gupta H, White CR, Handattu SP, Palgunachari MN, Chaddha M, Mishra VK, Segrest JP, Fogelman AM. PMID: 16680027.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    117. Oral amphipathic peptides as therapeutic agents. Expert Opin Investig Drugs. 2006 Jan; 15(1):13-21. Reddy ST, Anantharamaiah GM, Navab M, Hama S, Hough G, Grijalva V, Garber DW, Datta G, Fogelman AM. PMID: 16370930.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    118. An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I. Circ Res. 2005 Nov 25; 97(11):1085-6. Navab M, Anantharamaiah GM, Fogelman AM. PMID: 16306451.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    119. High-density lipoprotein function recent advances. J Am Coll Cardiol. 2005 Nov 15; 46(10):1792-8. Ansell BJ, Watson KE, Fogelman AM, Navab M, Fonarow GC. PMID: 16286161.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    120. Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice. Circ Res. 2005 Sep 16; 97(6):524-32. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Frank JS, Grijalva VR, Ganesh VK, Mishra VK, Palgunachari MN, Fogelman AM. PMID: 16100046.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    121. When pouring water on the fire makes it burn brighter. Cell Metab. 2005 Jul; 2(1):6-8. Fogelman AM. PMID: 16054094.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    122. An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2005 Sep; 25(9):1932-7. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Wagner AC, Hama S, Hough G, Bachini E, Garber DW, Mishra VK, Palgunachari MN, Fogelman AM. PMID: 15961700.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    123. The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med. 2005 May; 15(4):158-61. Navab M, Anantharamaiah GM, Fogelman AM. PMID: 16099381.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansAnimals
    124. D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2005 Jul; 25(7):1426-32. Navab M, Anantharamaiah GM, Hama S, Hough G, Reddy ST, Frank JS, Garber DW, Handattu S, Fogelman AM. PMID: 15845909.
      View in: PubMed   Mentions: 66     Fields:    Translation:AnimalsCells
    125. Apolipoprotein A-I mimetic peptides. Arterioscler Thromb Vasc Biol. 2005 Jul; 25(7):1325-31. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Yu N, Ansell BJ, Datta G, Garber DW, Fogelman AM. PMID: 15831812.
      View in: PubMed   Mentions: 100     Fields:    Translation:HumansAnimalsCells
    126. The double jeopardy of HDL. Ann Med. 2005; 37(3):173-8. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Hama S, Hough G, Bachini E, Grijalva VR, Wagner AC, Shaposhnik Z, Fogelman AM. PMID: 16019715.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimals
    127. Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal. Curr Opin Lipidol. 2004 Dec; 15(6):645-9. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Datta G, Garber D, Fogelman AM. PMID: 15529023.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    128. Anti-inflammatory properties of HDL. Rev Endocr Metab Disord. 2004 Dec; 5(4):351-8. Ansell BJ, Navab M, Watson KE, Fonarow GC, Fogelman AM. PMID: 15486468.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimalsCells
    129. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes. Circulation. 2004 Nov 16; 110(20):3252-8. Van Lenten BJ, Wagner AC, Navab M, Anantharamaiah GM, Hui EK, Nayak DP, Fogelman AM. PMID: 15533864.
      View in: PubMed   Mentions: 52     Fields:    Translation:HumansCells
    130. Antiinflammatory properties of HDL. Circ Res. 2004 Oct 15; 95(8):764-72. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. PMID: 15486323.
      View in: PubMed   Mentions: 453     Fields:    Translation:HumansCells
    131. Genetic basis of atherosclerosis: part II: clinical implications. Circulation. 2004 Oct 05; 110(14):2066-71. Lusis AJ, Fogelman AM, Fonarow GC. PMID: 15466657.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    132. Genetic basis of atherosclerosis: part I: new genes and pathways. Circulation. 2004 Sep 28; 110(13):1868-73. Lusis AJ, Fogelman AM, Fonarow GC. PMID: 15451808.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimals
    133. When good cholesterol goes bad. Nat Med. 2004 Sep; 10(9):902-3. Fogelman AM. PMID: 15340411.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    134. PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity. J Lipid Res. 2004 Oct; 45(10):1852-8. Yan D, Navab M, Bruce C, Fogelman AM, Jiang XC. PMID: 15258196.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    135. Potential role for mitogen-activated protein kinase phosphatase-1 in the development of atherosclerotic lesions in mouse models. Arterioscler Thromb Vasc Biol. 2004 Sep; 24(9):1676-81. Reddy ST, Nguyen JT, Grijalva V, Hough G, Hama S, Navab M, Fogelman AM. PMID: 15242861.
      View in: PubMed   Mentions: 16     Fields:    Translation:AnimalsCells
    136. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation. 2004 Jun 29; 109(25):3215-20. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G, Garber D, Fogelman AM. PMID: 15197147.
      View in: PubMed   Mentions: 135     Fields:    Translation:HumansAnimalsCells
    137. Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity. J Biol Chem. 2004 Jun 18; 279(25):26509-17. Datta G, Epand RF, Epand RM, Chaddha M, Kirksey MA, Garber DW, Lund-Katz S, Phillips MC, Hama S, Navab M, Fogelman AM, Palgunachari MN, Segrest JP, Anantharamaiah GM. PMID: 15075321.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    138. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res. 2004 Jun; 45(6):993-1007. Navab M, Ananthramaiah GM, Reddy ST, Van Lenten BJ, Ansell BJ, Fonarow GC, Vahabzadeh K, Hama S, Hough G, Kamranpour N, Berliner JA, Lusis AJ, Fogelman AM. PMID: 15060092.
      View in: PubMed   Mentions: 202     Fields:    Translation:HumansAnimalsCells
    139. Apparent paradox of low-fat "healthy" diets increasing plasma levels of oxidized low-density lipoprotein and lipoprotein(a). Arterioscler Thromb Vasc Biol. 2004 Mar; 24(3):392-3. Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. PMID: 15003971.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    140. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 2003 Dec 02; 108(22):2751-6. Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, Hough G, Rahmani S, Mottahedeh R, Dave R, Reddy ST, Fogelman AM. PMID: 14638544.
      View in: PubMed   Mentions: 215     Fields:    Translation:HumansCellsCTClinical Trials
    141. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism. Mol Cell. 2003 Oct; 12(4):805-16. Castrillo A, Joseph SB, Vaidya SA, Haberland M, Fogelman AM, Cheng G, Tontonoz P. PMID: 14580333.
      View in: PubMed   Mentions: 182     Fields:    Translation:AnimalsCells
    142. Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice. Circulation. 2003 Oct 07; 108(14):1735-9. Navab M, Hama S, Hough G, Fogelman AM. PMID: 14504179.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    143. Human apolipoprotein AI mimetic peptides for the treatment of atherosclerosis. Curr Opin Investig Drugs. 2003 Sep; 4(9):1100-4. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Hough G, Wagner A, Nakamura K, Garber DW, Datta G, Segrest JP, Hama S, Fogelman AM. PMID: 14582455.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    144. Oxidized lipids as mediators of coronary heart disease. Curr Opin Lipidol. 2002 Aug; 13(4):363-72. Navab M, Hama SY, Reddy ST, Ng CJ, Van Lenten BJ, Laks H, Fogelman AM, Ready ST. PMID: 12151851.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    145. Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation. 2002 Jan 22; 105(3):290-2. Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, Lallone R, Fogelman AM. PMID: 11804981.
      View in: PubMed   Mentions: 151     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Alan's Networks
    Concepts (586)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (64)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California